Company Snapshot
- Ticker
- VTR
- Name
- VTR
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 35385812120.000000
- Volume
- 3,508,508
- Avg Volume (3M)
- 2,838,560
VTR
VTR
Last update recent
78.71
+0.85
(+1.09%)
Market Cap
35385812120.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 5555020000.000000
- EPS
- 0.13
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 2.33%
- Net Income
- 238014000.000000
- Net Margin
- 4.28%
- Payout Ratio
- 345.92%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 148.67
- Forward P/E
- None
- P/S
- 6.37
- P/B
- 2.85
- Beta
- None
- Debt / Equity
- 1.03
- Current Ratio
- 0.63
- Return on Equity
- 0.02%
- Return on Assets
- 0.01%
Technicals & Returns
- Distance vs 200 DMA
- 15.6%
- 200 DMA
- 68.09
- Distance vs 50 DMA
- 4.99%
- 50 DMA
- 74.97
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries ? healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of prop Read more
- Name
- VTR
- Industry
- REIT - Healthcare Facilities
- CEO
- Ms. Debra A. Cafaro
- Employees
- 486
- IPO Date
- 1997-05-05
- Phone
- 877-483-6827
- Address
- None
- Website
- https://www.ventasreit.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-07-01 • $0.45
Latest News
Curated headlines from premium sources.
Key Reasons to Add Ventas Stock to Your Portfolio Right Now
VTR gains momentum as its healthcare real estate portfolio, research investments and solid balance sheet point to further growth potential.
Axa S.A. Has $21.05 Million Stake in Ventas, Inc. $VTR
Axa S.A. lifted its holdings in Ventas, Inc. (NYSE: VTR) by 58.8% during the undefined quarter, according to its most recent filing with the Securities and Exc…
Ventas Declares Quarterly Dividend of $0.48 Per Common Share
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The…
Ventas to Participate in Investor Meetings at Nareit's REITworld 2025 Annual Conference
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in investor meetings at Nareit'…
Ventas Announces Pricing of Senior Notes Offering
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that its wholly owned subsidiary, Ventas Realty, Limited Partner…
Ventas (NYSE:VTR) Reaches New 1-Year High – Time to Buy?
Ventas, Inc. (NYSE: VTR - Get Free Report)'s stock price reached a new 52-week high during trading on Friday. The company traded as high as $80.67 and last tra…